NRSN NeuroSense Therapeutics Ltd.
$0.74▼ -2.63%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$26.71M
P/E Ratio
–
Div Yield
–%
52W Range
0.63 - 2.60
% vs 50 MA
-3.69%
% vs 200 MA
-20.68%
RSI-14
42.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.24
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
N/A
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Avg +0.62 · 4 posts
DDTradeNewsMy pick for 2025
r/wallstreetbets · Dec 21, 2024
The post presents a strong case for NRSN, highlighting key data, CEO action, and potential partnerships.
very_positive
+0.80
DDDiscussionMy Unconventional Bet on NeuroTech: Could It Be the Next Big Thing?
r/wallstreetbets · Aug 13, 2024
The post discusses NRSN within the context of emerging neurotech companies, indicating some level of interest.
positive
+0.30
NewsDiscussionNRSN finished phase 2 for ALS disease ($673M market) with great results (link in body), an oppty?
r/options · Jul 10, 2024
Significant positive news regarding a potential cure for ALS drives strong bullish sentiment.
positive
+0.80
NewsDiscussionTradeNRSN finished phase 2 for ALS disease ($673M market) with great results (news link in the body), went down yesterday, thinking can be an opportunity to buy.
r/investing · Jul 10, 2024
The post highlights positive results and a potential buying opportunity, indicating bullish sentiment.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.